Understanding lung issues in patients with blood disorders
Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases
New Valley University · NCT06350526
This study looks at lung problems in people with blood disorders to see what causes them and how to improve their diagnosis and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | New Valley University (other) |
| Locations | 1 site (Asyūţ) |
| Trial ID | NCT06350526 on ClinicalTrials.gov |
What this trial studies
This observational study aims to characterize pulmonary complications in patients diagnosed with hematological diseases. It focuses on identifying both infectious and non-infectious causes of lung issues, which can arise from the disease itself, comorbidities, or treatments. The study involves comprehensive diagnostic assessments, including blood tests and monitoring of respiratory function, to better understand the complexities of lung involvement in these patients. By analyzing the data collected, the study seeks to improve early diagnosis and treatment strategies for pulmonary complications.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with hematological diseases who exhibit pulmonary manifestations.
Not a fit: Patients under 18 years old or those without evidence of lung involvement will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and treatment protocols for lung complications in patients with hematological diseases.
How similar studies have performed: While there is existing literature on pulmonary complications in hematological diseases, this study's specific focus on comprehensive characterization is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients aged 18 years or older diagnosed with hematological diseases and documented pulmonary manifestations during their disease course Exclusion Criteria: 1. Patients aged under 18 years. 2. Patients without demonstrable evidence of lung involvement. 3. Patients with incomplete medical records or insufficient data to analyze.
Where this trial is running
Asyūţ
- Assiut University Hospital — Asyūţ, Egypt (RECRUITING)
Study contacts
- Study coordinator: Asmaa N Hussein, MD
- Email: asmaanady_1010@med.nvu.edu.eg
- Phone: 01065161752
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hematologic Diseases